{
  "id": "chronic-spontaneous-urticaria",
  "title": "Chronic spontaneous urticaria",
  "lang": "en",
  "source_lang": "en",
  "summary": "Chronic spontaneous urticaria is a disorder involving recurrent hives, deeper skin swelling, or both for more than six weeks without a specific reproducible trigger.",
  "category": "health",
  "subcategory": "diseases",
  "type": "concept",
  "aliases": [
    "Chronic idiopathic urticaria",
    "CSU"
  ],
  "generated_at": "2026-11-05",
  "model": "pro/gpt-6.1-sol",
  "url": "https://aiwiki.page/en/chronic-spontaneous-urticaria/",
  "translations": {
    "zh-Hans": {
      "url": "https://aiwiki.page/zh/chronic-spontaneous-urticaria/",
      "json": "https://aiwiki.page/zh/chronic-spontaneous-urticaria.json"
    }
  },
  "sections": [
    {
      "heading": "",
      "text": "Chronic spontaneous urticaria (CSU) is a form of urticaria characterized by recurrent itchy wheals, angioedema, or both over more than six weeks, without a specific, consistently reproducible external trigger. Individual wheals usually disappear within 24 hours, although new ones may continue to appear elsewhere. The condition is driven by activation of mast cells in the skin and is not usually explained by an external allergy. Its course varies from months to many years."
    },
    {
      "heading": "Terminology and classification",
      "text": "Chronic refers to the duration of the recurring disorder, not to the persistence of an individual skin lesion. Symptoms may occur daily or intermittently.\n\nSpontaneous distinguishes CSU from chronic inducible urticaria, in which particular stimuli—such as cold, heat, pressure, or scratching—reliably provoke symptoms. Spontaneous and inducible forms can coexist.\n\nThe older term chronic idiopathic urticaria remains in use, including in some drug labels. The shift toward spontaneous reflects the recognition that an underlying biological mechanism, particularly autoimmunity, can sometimes be identified even when there is no reproducible external trigger."
    },
    {
      "heading": "Clinical features",
      "text": "Wheals are raised, transient areas of superficial skin swelling, usually accompanied by itching. They vary considerably in size and shape and may merge into larger patches. They generally resolve without bruising or scarring.\n\nAngioedema involves deeper tissues and commonly affects the lips, eyelids, hands, or feet. It may cause tightness, discomfort, or pain rather than itching and can take up to approximately 72 hours to resolve. Some people have both wheals and angioedema; others have only one manifestation.\n\nSymptoms often fluctuate substantially. Itching and visible swelling can disrupt sleep, concentration, work, and social activities, affecting health-related quality of life. CSU is not contagious, and its presence does not by itself establish a food or environmental allergy."
    },
    {
      "heading": "Biological mechanisms",
      "text": "Mast cells are central to CSU. When activated, they release histamine and other mediators that increase the permeability of small blood vessels and stimulate sensory nerves. These effects produce swelling, redness, and itching.\n\nTwo autoimmune mechanisms have been described:\n\n- Type I autoimmune, or autoallergic, mechanisms: immunoglobulin E (IgE) antibodies recognize the body’s own molecules and can participate in mast-cell activation.\n- Type IIb autoimmune mechanisms: autoantibodies, commonly of the IgG class, target IgE or its high-affinity receptor, FcεRI, and can activate mast cells and basophils.\n\nThese mechanisms do not account for every case, and they may overlap. Routine clinical testing does not always establish a specific mechanism.\n\nAutoimmune thyroid disease is associated with CSU, but detecting thyroid antibodies does not prove that thyroid disease is causing the skin symptoms. More generally, an association with an autoimmune disease is not equivalent to a demonstrated causal relationship.\n\nCertain exposures, including nonsteroidal anti-inflammatory drugs, can exacerbate CSU in susceptible individuals. Such aggravating factors are distinct from the consistently reproducible stimuli that define inducible urticaria. Classical food allergy is an uncommon explanation for persistent spontaneous urticaria."
    },
    {
      "heading": "Diagnosis and differential diagnosis",
      "text": "Diagnosis is primarily clinical, based on the appearance, duration, and recurrence of lesions. A medical history and physical examination establish the symptom pattern and assess possible alternative explanations. Photographs can help document lesions that have disappeared before examination.\n\nLaboratory investigation is usually limited and guided by clinical findings. A complete blood count and inflammatory markers may form part of an initial evaluation. Additional investigations, such as thyroid testing, total IgE, or tests of autoimmunity, depend on the clinical context and specialist assessment. Broad allergy panels do not generally explain CSU in the absence of a history suggesting a particular allergy.\n\nImportant aspects of differential diagnosis include:\n\n- Urticarial vasculitis: lesions often remain in the same place for more than 24 hours, may burn or hurt, and may leave bruising or discoloration. A skin biopsy can help establish the diagnosis.\n- Bradykinin-mediated angioedema: including hereditary forms and angioedema associated with angiotensin-converting enzyme inhibitors. This typically occurs without wheals and has a different mechanism and treatment.\n- Autoinflammatory disorders: some cause urticaria-like eruptions accompanied by fever, joint symptoms, or other systemic findings.\n- Chronic inducible urticaria: identified by a reproducible relationship to a particular physical or other stimulus.\n\nCSU is also distinct from anaphylaxis, an acute systemic reaction that can include respiratory or circulatory compromise as well as skin symptoms."
    },
    {
      "heading": "Assessment of disease activity",
      "text": "Because symptoms fluctuate, assessment often uses structured patient-reported outcomes rather than a single examination.\n\nThe Urticaria Activity Score over seven days, or UAS7, combines daily ratings of wheal number and itch severity. Scores range from 0 to 42, with higher values indicating greater activity. It does not directly measure angioedema.\n\nThe Urticaria Control Test evaluates overall disease control. Separate instruments assess angioedema activity and disease-specific quality of life. These measures distinguish symptom activity, control, and life impact, which are related but not identical."
    },
    {
      "heading": "Treatment",
      "text": "Treatment aims to suppress symptoms and maintain disease control. Established treatments generally control the manifestations rather than provide a guaranteed permanent cure.\n\nSecond-generation H1 antihistamines are standard initial medicines. They block histamine signaling and generally cause less sedation than first-generation agents. Clinical guidelines include supervised dose escalation for inadequate control; such dosing may be outside the licensed dose in some jurisdictions.\n\nFor disease insufficiently controlled by antihistamines, established specialist treatments include:\n\n- Omalizumab, an anti-IgE monoclonal antibody that reduces free IgE and alters IgE-receptor expression.\n- Ciclosporin, an immunosuppressive medicine used in selected refractory cases, with monitoring because of potential kidney effects, hypertension, and drug interactions.\n\nLong-term systemic corticosteroids are generally avoided because of cumulative adverse effects. Brief courses have a limited role in severe exacerbations rather than ongoing control.\n\nTreatment selection depends on symptom burden, response, adverse effects, coexisting conditions, and local regulatory approvals. Evidence for broadly restrictive diets or routine treatment of presumed infections without supporting findings is insufficient to establish these as general treatments for CSU."
    },
    {
      "heading": "Epidemiology and course",
      "text": "CSU occurs in children and adults, with many adult studies reporting a predominance among women. Estimates of frequency differ by population and study methods.\n\nSpontaneous remission is common, but its timing is unpredictable. Some cases resolve within a few years, while others persist considerably longer or recur after remission. No single routinely available test reliably predicts an individual’s disease duration."
    }
  ],
  "links": [
    "urticaria",
    "allergy",
    "autoimmunity",
    "pain",
    "health-related-quality-of-life",
    "mast-cell",
    "histamine",
    "autoimmune-disease",
    "food-allergy",
    "diagnosis",
    "medical-history",
    "physical-examination",
    "complete-blood-count",
    "differential-diagnosis",
    "biopsy",
    "anaphylaxis",
    "patient-reported-outcome",
    "antihistamine",
    "monoclonal-antibody",
    "corticosteroid"
  ],
  "sources": [],
  "license": "https://creativecommons.org/licenses/by/4.0/"
}